Enfusion (ENFN)
(Delayed Data from NYSE)
$8.21 USD
+0.14 (1.73%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $8.22 +0.01 (0.12%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Cash flow Statements
Fiscal Year End for Enfusion, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 9.25 | -13.26 | -282.24 | 4.06 | 12.66 |
Depreciation/Amortization & Depletion | 10.08 | 6.37 | 4.20 | 2.35 | 1.18 |
Net Change from Assets/Liabilities | -9.43 | -5.60 | -14.74 | -5.76 | -1.80 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 15.74 | 26.65 | 292.47 | 1.01 | 0.27 |
Net Cash From Operating Activities | 25.63 | 14.16 | -0.32 | 1.67 | 12.31 |
Property & Equipment | -9.67 | -7.93 | -8.01 | -5.07 | -4.43 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -9.67 | -7.93 | -8.01 | -5.07 | -4.43 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 17.32 | 0.00 | 172.70 | 16.63 | -0.14 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -100.00 | 70.91 | 27.70 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -60.41 | -7.96 | -13.85 | -75.98 | -35.10 |
Net Cash from Financing Activities | -43.08 | -7.96 | 58.85 | 11.56 | -7.54 |
Effect of Exchange Rate Changes | 0.18 | -0.09 | -0.09 | -0.12 | -0.09 |
Net Change In Cash & Equivalents | -26.94 | -1.82 | 50.43 | 8.04 | 0.25 |
Cash at Beginning of Period | 62.55 | 64.37 | 13.94 | 5.90 | 5.65 |
Cash at End of Period | 35.60 | 62.55 | 64.37 | 13.94 | 5.90 |
Diluted Net EPS | 0.07 | -0.10 | -2.26 | NA | NA |
Fiscal Year End for Enfusion, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 1.79 | -0.76 | 9.25 | 8.35 | 5.69 |
Depreciation/Amortization & Depletion | 5.66 | 2.73 | 10.08 | 6.49 | 3.96 |
Net Change from Assets/Liabilities | -13.78 | -9.06 | -9.43 | -6.56 | -8.09 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 15.17 | 8.63 | 15.74 | 10.77 | 5.38 |
Net Cash From Operating Activities | 8.85 | 1.53 | 25.63 | 19.05 | 6.94 |
Property & Equipment | -5.45 | -2.75 | -9.67 | -7.38 | -4.77 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -3.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -8.45 | -2.75 | -9.67 | -7.38 | -4.77 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 17.32 | 17.32 | 9.69 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -0.14 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -1.25 | -1.37 | -60.41 | -59.83 | -46.89 |
Net Cash from Financing Activities | -1.39 | -1.37 | -43.08 | -42.50 | -37.20 |
Effect of Exchange Rate Changes | -0.16 | -0.12 | 0.18 | -0.06 | 0.25 |
Net Change In Cash & Equivalents | -1.16 | -2.71 | -26.94 | -30.89 | -34.77 |
Cash at Beginning of Period | 35.60 | 35.60 | 62.55 | 62.55 | 62.55 |
Cash at End of Period | 34.45 | 32.89 | 35.60 | 31.65 | 27.77 |
Diluted Net EPS | 0.02 | -0.01 | 0.01 | 0.02 | 0.01 |